Andrew D. Leavitt

Professor and Medical Director
Adult Hemophilia Treatment Center, University of California San Francisco, San Francisco, CA, USA
San Francisco, California, United States

Presentation(s):

• OC 20.1 - Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: Results from GENEr8-1

  Sunday, June 25, 2023
  14:45 – 15:00 ET

• PB1241 - ATHN 11: Observational Study of Long-Term Outcomes of Liver Transplantation

  Tuesday, June 27, 2023
  18:30 – 19:30 ET